European Chemical Industry News & Insights

LANXESS Invests EUR 20 Million in Cresol Production Expansion

At a glance
  • LANXESS is expanding cresol production by 20% at Leverkusen by mid-2013.
  • The investment amounts to EUR 20 million.
  • The first expansion step in 2010 increased capacities by up to 60%.
  • The aromatics network includes seven large-scale plants and produces over 60 products.

Investment and Expansion

LANXESS is expanding cresol production at its Leverkusen site, aiming to increase capacity by 20% by mid-2013. This expansion involves an investment of EUR 20 million, reinforcing the company's commitment to Germany and North Rhine-Westphalia as industrial locations.

Strategic Growth

The expansion is part of LANXESS's long-term asset strategy to maintain its world market position. The company plans to boost capacities of other high-grade intermediates to meet customer demand and ensure reliable delivery.

Aromatics Network

The LANXESS aromatics network consists of seven large-scale plants, primarily in Leverkusen, with additional finishing stages in Krefeld-Uerdingen, Dormagen, and Brunsbüttel. The network processes petrochemical raw materials benzene and toluene into over 60 high-quality intermediates used in various industries, including pharmaceuticals, crop protection, and resins.

Technological Advancements

LANXESS employs modern technologies and special catalysts to optimize chemical reactions, ensuring the production of marketable, high-grade intermediates. The company's global sales network and industry expertise support its success in marketing these products.

Production and Logistics

Approximately 500 employees work within the aromatics network, which produces and markets nearly 300,000 metric tons of intermediates annually. The integrated plant network in Leverkusen, connected via pipeline systems, offers significant productivity and logistics advantages. The German plants in Dormagen, Krefeld, and Brunsbüttel are connected by rail and road transport, further enhancing efficiency.